Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo
- 8 May 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (19), 7893-7898
- https://doi.org/10.1073/pnas.0702439104
Abstract
The pH-selective insertion and folding of a membrane peptide, pHLIP [pH (low) insertion peptide], can be used to target acidic tissue in vivo, including acidic foci in tumors, kidneys, and inflammatory sites. In a mouse breast adenocarcinoma model, fluorescently labeled pHLIP finds solid acidic tumors with high accuracy and accumulates in them even at a very early stage of tumor development. The fluorescence signal is stable for >4 days and is approximately five times higher in tumors than in healthy counterpart tissue. In a rat antigen-induced arthritis model, pHLIP preferentially accumulates in inflammatory foci. pHLIP also maps the renal cortical interstitium; however, kidney accumulation can be reduced significantly by providing mice with bicarbonate-containing drinking water. The peptide has three states: soluble in water, bound to the surface of a membrane, and inserted across the membrane as an alpha-helix. At physiological pH, the equilibrium is toward water, which explains its low affinity for cells in healthy tissue; at acidic pH, titration of Asp residues shifts the equilibrium toward membrane insertion and tissue accumulation. The replacement of two key Asp residues located in the transmembrane part of pHLIP by Lys or Asn led to the loss of pH-sensitive insertion into membranes of liposomes, red blood cells, and cancer cells in vivo, as well as to the loss of specific accumulation in tumors. pHLIP nanotechnology introduces a new method of detecting, targeting, and possibly treating acidic diseased tissue by using the selective insertion and folding of membrane peptides.Keywords
This publication has 28 references indexed in Scilit:
- Translocation of molecules into cells by pH-dependent insertion of a transmembrane helixProceedings of the National Academy of Sciences of the United States of America, 2006
- Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor MicroenvironmentMolecular Cancer Research, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Fluorescence Imaging of Tumors In VivoCurrent Medicinal Chemistry, 2005
- Tumor imaging by means of proteolytic activation of cell-penetrating peptidesProceedings of the National Academy of Sciences of the United States of America, 2004
- Tissue pH Determination for the Detection of Metabolically Active, Inflamed Vulnerable Plaques Using Near-Infrared Spectroscopy: An in-vitro Feasibility StudyCardiology, 2004
- Tissue and intracellular pH in normal periarticular soft tissue and during different phases of antigen induced arthritis in the rat.1999
- Physiological characterization of mBSA antigen induced arthritis in the rat. I. Vascular leakiness and pannus growth.1998
- Dietary HCO3 reduces distal tubule acidification by increasing cellular HCO3 secretionAmerican Journal of Physiology-Renal Physiology, 1996
- Lateral organization of membranes and cell shapesBiophysical Journal, 1981